The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective.
about
Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions.Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference.Chordoid meningioma in a pediatric patient with tuberous sclerosis complex.Education of a child neurologist: developmental neuroscience relevant to child neurology.mTOR Inhibitors in Tuberous Sclerosis Complex.Tuberous sclerosis associated with polycystic kidney disease: effects of rapamycin after renal transplantation.Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma.Is mTOR inhibition a systemic treatment for tuberous sclerosis?mTOR Inhibition: From Aging to Autism and Beyond.Subependymal giant cell astrocytomas in patients with tuberous sclerosis complex: considerations for surgical or pharmacotherapeutic intervention.Subependymal giant cell astrocytoma: current concepts, management, and future directions.The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.Successful everolimus therapy for SEGA in pediatric patients with tuberous sclerosis complex.Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex.Subependymal nodules and giant cell tumours in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation.Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex.
P2860
Q30747071-E526B95B-07AD-4FEE-87CC-D769CE1BBF7DQ33757948-DF2D9BD9-3981-41B7-9105-F38430F094AEQ34161964-33336F4D-40FF-4067-B951-49863BF22A91Q35789190-9FAC3ECA-2602-4BB1-BE14-36142DFBCC3AQ36460639-97A4C19D-DCC3-4EAA-8DB3-4347E58E958FQ36582523-1B42352F-8763-418E-9B6D-6B3B06B4C52EQ36659706-B1AE1F92-F5A6-4823-9569-AA339C16AC80Q37359517-9EE0C608-424F-4998-A98E-F12096508EF4Q37385781-DA442D16-9F2B-48B7-9A48-72A9342617C4Q38150748-BF49514B-FECE-45F8-BFAB-C8053A6ABDE5Q38189289-BC8E4373-2883-4F79-8BBA-EB5F9E4CDB9CQ38755497-B8EAA29B-2E41-4781-8E8F-D374E2752674Q43788777-8E1B8CF4-BE62-401D-9F55-22ADE7374A20Q43814142-927B26E5-ED0E-4744-8908-237B5349B07FQ44136131-3E7CC3E6-D8F8-4A96-BFA2-02CA32B72FB5Q48593173-7B12443B-FA8D-4359-80C7-212573BBFD39
P2860
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The management of subependymal ...... is: a clinician's perspective.
@en
The management of subependymal ...... is: a clinician's perspective.
@nl
type
label
The management of subependymal ...... is: a clinician's perspective.
@en
The management of subependymal ...... is: a clinician's perspective.
@nl
prefLabel
The management of subependymal ...... is: a clinician's perspective.
@en
The management of subependymal ...... is: a clinician's perspective.
@nl
P2093
P2860
P1476
The management of subependymal ...... is: a clinician's perspective.
@en
P2093
Mariangela Pinci
Paolo Curatolo
Roberta Bombardieri
Romina Moavero
P2860
P2888
P304
P356
10.1007/S00381-011-1406-0
P577
2011-02-09T00:00:00Z